159 related articles for article (PubMed ID: 2865128)
1. [The future of biological psychiatry].
Linnoila M
Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128
[No Abstract] [Full Text] [Related]
2. [Biological psychiatry (neuropsychiatry)--status and perspectives for for the 1990s].
Rosenberg R
Nord Med; 1993; 108(5):139-44. PubMed ID: 8098866
[TBL] [Abstract][Full Text] [Related]
3. Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
Greenshaw AJ
J Psychiatry Neurosci; 2003 Jul; 28(4):247-50. PubMed ID: 12921219
[No Abstract] [Full Text] [Related]
4. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
Lesch KP; Beckmann H
Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894
[No Abstract] [Full Text] [Related]
5. Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist.
Stahl SM
J Clin Psychiatry; 2003 Oct; 64(10):1145-6. PubMed ID: 14658960
[No Abstract] [Full Text] [Related]
6. [Stimulant amino acids, glutamate receptors and pathology of the central nervous system].
Raevskiĭ KS
Patol Fiziol Eksp Ter; 1990; (1):3-9. PubMed ID: 1972271
[No Abstract] [Full Text] [Related]
7. Progress in psychopharmacology.
Post RM; Bunney WE
Curr Psychiatr Ther; 1980; 19():69-87. PubMed ID: 6109596
[No Abstract] [Full Text] [Related]
8. New psychoactive drugs.
Murray JB
Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
[TBL] [Abstract][Full Text] [Related]
9. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
Wunderlich H; Wunderlich HP
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615
[No Abstract] [Full Text] [Related]
10. [The impact of molecular biology on psychiatric diseases].
Salín-Pascual RJ; Alcocer Castillejos N
Rev Invest Clin; 2003; 55(2):216-9. PubMed ID: 12827930
[No Abstract] [Full Text] [Related]
11. [Psychopharmacotherapy in child psychiatry (author's transl)].
Eggers C
MMW Munch Med Wochenschr; 1980 Dec; 122(51-52):1843-8. PubMed ID: 6110186
[TBL] [Abstract][Full Text] [Related]
12. [Dimensional approach to trans-nosographic study of psychotropic drugs].
Jouvent R
Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355
[No Abstract] [Full Text] [Related]
13. Mental disorders. Targeting the brain.
Hooper J
Time; 1996; 148(14):46-50. PubMed ID: 10161473
[No Abstract] [Full Text] [Related]
14. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists.
Heckers S; Konradi C
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):1-22. PubMed ID: 10674188
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
Voirol P; Eap CB; Baumann P
Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
[No Abstract] [Full Text] [Related]
16. [Psychopharmaceuticals as instruments for research].
Vinar O
Cesk Psychiatr; 1988 Feb; 84(1):28-35. PubMed ID: 2896551
[No Abstract] [Full Text] [Related]
17. Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology.
Hyman SE
Psychosomatics; 1988; 29(3):254-63. PubMed ID: 2900534
[No Abstract] [Full Text] [Related]
18. [Psychiatrist and the change of psychiatry].
Degrell I
Neuropsychopharmacol Hung; 2008 Mar; 10(1):1-2. PubMed ID: 18771013
[No Abstract] [Full Text] [Related]
19. [Psychiatry--chemistry of the mind].
Larsen L
Sygeplejersken; 1997 Nov; 97(46):18-20. PubMed ID: 9431124
[No Abstract] [Full Text] [Related]
20. [Neurotransmitters and behavioral disorders].
Allain H; Schuck S
Encephale; 1998 Jul; 24 Spec No 1():34-7. PubMed ID: 9809253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
